The discriminative role of PROX ‐1 immunohistochemistry between venous malformation and lymphatic malformation of the deep type with no visible diagnostic surface skin lesion
Journal of Cutaneous Pathology · 2024
DOI: 10.1111/cup.14569 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cutaneous Pathology, 2024. Verfasst von Seok-Jong Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, School of Medicine, Kyungpook National University, Daegu, South Korea. Hauptthemen laut MEDLINE: Vascular Malformations, Lymphatic Vessels, Skin Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: National Research Foundation of Korea (NRF).
Abstract (Originalsprache)
Background
Venous malformations (VMs) are distinguished from lymphatic malformations (LMs) when specific diagnostic skin lesions are present. In the deep type, this is difficult by clinico‐radiologic evaluation alone. We aimed to investigate the usefulness of lymphatic vessel endothelial cell (LEC) markers for the differential diagnosis of the deep VMs and LMs.
Methods
A retrospective study was conducted based on the medical records of patients with VMs and LMs who underwent biopsy with both D2‐40 and PROX‐1 immunohistochemistry. We compared the initial clinico‐radiological diagnosis with the final pathological diagnosis and identified which ones showed a difference.
Results
From 261 patients who had VMs and LMs, 111 remained after the exclusion of those who showed definite surface diagnostic features. After pathological diagnosis with the expressions of D2‐40 and PROX‐1, 38 of 111 (34.2%) patients' final diagnoses were changed. Among these 38 cases, diagnosis was not changed by D2‐40 positivity alone, but changed by PROX‐1 positivity alone (52.6%) or by both (47.4%). The diagnostic changes were more frequent in the deep category (43.7%) than in the superficial category.
Conclusions
Identifying the expression of D2‐40, and especially PROX‐1, in the differential diagnosis of VMs and LMs may provide important treatment guidelines and understanding their natural course.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, School of Medicine, Kyungpook National University, Daegu, South Korea.
- Gounmi Dermatology Clinic, Daegu, South Korea.
- Department of Radiology, School of Medicine, Kyungpook National University, Daegu, South Korea.
- Department of Vascular Surgery, School of Medicine, Kyungpook National University, Daegu, South Korea.
- Department of Pediatrics, School of Medicine, Kyungpook National University, Daegu, South Korea.
- Department of Plastic and Reconstructive Surgery, School of Medicine, Kyungpook National University, Daegu, South Korea.
ORCID-Profile: Seok-Jong Lee, Nam Gyoung Ha, Ho Youn Kim, Jong Min Lee, Sang Yub Lee, Seung Huh, Ji Yoon Kim, Ho Yun Chung
Förderung
- National Research Foundation of Korea (NRF)
Zitieren
APA
Lee, S. J., Ha, N. G., Kim, H. Y., Lee, J. M., Lee, S. Y., Huh, S., Kim, J. Y., & Chung, H. Y. (2024). The discriminative role of PROX ‐1 immunohistochemistry between venous malformation and lymphatic malformation of the deep type with no visible diagnostic surface skin lesion. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.14569
Vancouver
Lee SJ, Ha NG, Kim HY, Lee JM, Lee SY, Huh S, et al. The discriminative role of PROX ‐1 immunohistochemistry between venous malformation and lymphatic malformation of the deep type with no visible diagnostic surface skin lesion. Journal of Cutaneous Pathology. 2024. doi:10.1111/cup.14569
BibTeX
@article{Lee2024,
author = {Lee, Seok-Jong and Ha, Nam Gyoung and Kim, Ho Youn and Lee, Jong Min and Lee, Sang Yub and Huh, Seung and Kim, Ji Yoon and Chung, Ho Yun},
title = {The discriminative role of PROX ‐1 immunohistochemistry between venous malformation and lymphatic malformation of the deep type with no visible diagnostic surface skin lesion},
journal = {Journal of Cutaneous Pathology},
year = {2024},
doi = {10.1111/cup.14569}
}
EUVIMED